Compare OIS & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OIS | FLGT |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.6M | 511.0M |
| IPO Year | 2000 | 2016 |
| Metric | OIS | FLGT |
|---|---|---|
| Price | $8.56 | $21.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $14.00 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 447.0K | 263.5K |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $1,088,133,000.00 | $18,730,000.00 |
| Revenue This Year | $3.12 | $10.09 |
| Revenue Next Year | $5.89 | $12.18 |
| P/E Ratio | $71.67 | ★ N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $5.50 | $13.46 |
| 52 Week High | $14.50 | $31.04 |
| Indicator | OIS | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 65.84 |
| Support Level | $7.97 | $19.12 |
| Resistance Level | $8.93 | $21.56 |
| Average True Range (ATR) | 0.31 | 0.59 |
| MACD | -0.03 | 0.14 |
| Stochastic Oscillator | 52.48 | 98.68 |
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.